MRK · News · 20261102N

WINREVAIR Demand Growth

Merck & Co., Inc. · 2026-11-02 · Importance 57 · Surprise 64

Merck’s WINREVAIR sales reached $694 million, up 93% year over year, according to the October 29 release cited in the report. The article describes the medicine as fast-growing but says it represented roughly 3.8% of Merck’s approximately $18.1 billion in total revenue. Its growth therefore remains a relatively small contributor to the company’s overall business, making the pace of scaling a key market question.